{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:18:50Z","timestamp":1787019530212,"version":"build-2736575974"},"reference-count":13,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We retrospectively evaluated 18fluoro-2-deoxyglucose positron emission tomography (FDG-PET) scans in 172 patients with lymphoma and correlated results with pathologic diagnosis using the World Health Organization (WHO) classification system. In total, FDG-PET detected disease in at least one site in 161 patients (94%) and failed to detect disease in 11 patients (6%). The most frequent lymphoma diagnoses were diffuse large B-cell lymphoma (LBCL; n\u2009=\u200951), Hodgkin lymphoma (HL; n\u2009=\u200947), follicular lymphoma (FL; n\u2009=\u200942), marginal zone lymphoma (MZL; n\u2009=\u200912), mantle cell lymphoma (MCL; n\u2009=\u20097), and peripheral T-cell lymphoma (PTCL; n\u2009=\u20095). FDG-PET detected disease in 100% of patients with LBCL and MCL and in 98% of patients with HL and FL. In contrast, FDG-PET detected disease in only 67% of MZL and 40% of PTCL. Comparison with bone marrow biopsies showed that FDG-PET was not reliable for detection of bone marrow involvement in any lymphoma subtype.<\/jats:p>","DOI":"10.1182\/blood-2002-09-2778","type":"journal-article","created":{"date-parts":[[2003,5,5]],"date-time":"2003-05-05T15:24:00Z","timestamp":1052148240000},"page":"3875-3876","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":367,"title":["Utility of FDG-PET scanning in lymphoma by WHO classification"],"prefix":"10.1182","volume":"101","author":[{"given":"Rebecca","family":"Elstrom","sequence":"first","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Guan","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Baker","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khozaim","family":"Nakhoda","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne","family":"Vergilio","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Zhuang","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Pitsilos","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bagg","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Downs","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mehrotra","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abass","family":"Alavi","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Schuster","sequence":"additional","affiliation":[{"name":"From the Abramson Family Cancer Research Institute of the University of Pennsylvania, Philadelphia; and the Departments of Medicine, Nuclear Medicine, and Laboratory Medicine and Pathology, University of Pennsylvania Medical Center, Philadelphia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111703015427100_B1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells.","volume":"123","author":"Warburg","year":"1956","journal-title":"Science."},{"key":"2019111703015427100_B2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/snuc.2002.29272","article-title":"Whole-body FDG-PET imaging in the management of patients with cancer.","volume":"32","author":"Hustinx","year":"2002","journal-title":"Semin Nucl Med."},{"key":"2019111703015427100_B3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1365-2141.2001.03169.x","article-title":"Can positron emission tomography with [(18)F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?","volume":"115","author":"Spaepen","year":"2001","journal-title":"Br J Haematol."},{"key":"2019111703015427100_B4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2141.2001.03147.x","article-title":"Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma.","volume":"115","author":"Naumann","year":"2001","journal-title":"Br J Haematol."},{"key":"2019111703015427100_B5","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1011169332265","article-title":"Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL).","volume":"12","author":"Jerusalem","year":"2001","journal-title":"Ann Oncol."},{"key":"2019111703015427100_B6","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1182\/blood.V86.9.3522.bloodjournal8693522","article-title":"Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose.","volume":"86","author":"Lapela","year":"1995","journal-title":"Blood."},{"key":"2019111703015427100_B7","first-page":"1211","article-title":"Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study.","volume":"32","author":"Leskinen-Kallio","year":"1991","journal-title":"J Nucl Med."},{"key":"2019111703015427100_B8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1148\/radiology.203.3.9169707","article-title":"Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.","volume":"203","author":"Moog","year":"1997","journal-title":"Radiology."},{"key":"2019111703015427100_B9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1148\/radiology.190.1.8259386","article-title":"Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.","volume":"190","author":"Newman","year":"1994","journal-title":"Radiology."},{"key":"2019111703015427100_B10","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1023\/A:1008312726163","article-title":"Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type.","volume":"10","author":"Hoffmann","year":"1999","journal-title":"Ann Oncol."},{"key":"2019111703015427100_B11","first-page":"1790","article-title":"Predicting malignancy grade with PET in non-Hodgkin's lymphoma.","volume":"36","author":"Rodriguez","year":"1995","journal-title":"J Nucl Med."},{"key":"2019111703015427100_B12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s002590050275","article-title":"Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography.","volume":"25","author":"Stumpe","year":"1998","journal-title":"Eur J Nucl Med."},{"key":"2019111703015427100_B13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9343(01)01117-2","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.","volume":"112","author":"Wirth","year":"2002","journal-title":"Am J Med."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/10\/3875\/1259374\/h81003003875.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/10\/3875\/1259374\/h81003003875.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T03:02:01Z","timestamp":1573959721000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/10\/3875\/19200\/Utility-of-FDGPET-scanning-in-lymphoma-by-WHO"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,15]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,5,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-09-2778","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,5,15]]}}}